2015
DOI: 10.1038/npp.2015.187
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Escitalopram Administration on Face Processing in Intermittent Explosive Disorder: An fMRI Study

Abstract: The neurobiological underpinnings of intermittent explosive disorder (IED) are traditionally linked to deficiencies in the serotonergic system. In this study, we investigated the effects of escitalopram, a selective serotonin reuptake inhibitor (SSRI), on brain activation during face processing. We expected that escitalopram would reduce amygdala activity in IED and in addition, we explored the effect in other social-emotional-related brain regions. A total of 17 subjects with current IED and 14 healthy contro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
10
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(12 citation statements)
references
References 64 publications
2
10
0
Order By: Relevance
“…Murphy and colleagues (2009) reported increased amygdala responses to implicit processing of fearful faces after the SSRI. This finding has been supported and extended in several similar studies; for example, citalopram (Bigos et al 2008) and escitalopram (Cremers et al 2016) increased amygdala reactivity during explicit facial emotion recognition. In contrast, amygdala activation was attenuated during implicit recognition of facial emotions (Del-Ben et al 2005; Anderson et al 2007).…”
Section: Introductionsupporting
confidence: 61%
“…Murphy and colleagues (2009) reported increased amygdala responses to implicit processing of fearful faces after the SSRI. This finding has been supported and extended in several similar studies; for example, citalopram (Bigos et al 2008) and escitalopram (Cremers et al 2016) increased amygdala reactivity during explicit facial emotion recognition. In contrast, amygdala activation was attenuated during implicit recognition of facial emotions (Del-Ben et al 2005; Anderson et al 2007).…”
Section: Introductionsupporting
confidence: 61%
“…The findings concerning the TPJ are also relevant because this region has been proposed as a target for therapeutic intervention. Several drugs may affect its function, for instance, drugs that alter norepinephrine (Strange and Dolan, 2007), selective serotonin reuptake inhibitors (Cremers et al., 2016) and intranasal oxytocin (Hu et al., 2016). In addition, the TPJ is a promising target for neuromodulation techniques such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) (Donaldson et al., 2015).…”
Section: Discussionmentioning
confidence: 99%
“…In relation to pharmacological treatments, drugs that alter norepinephrine may influence TPJ function (e.g. during attention related tasks: Strange & Dolan, 2007), whereas selective serotonin reuptake inhibitors have been reported to enhance task-related activation in this region on a social cognition task in patients with intermittent explosive disorder (Cremers et al, 2016) and on a language processing task in depression (Abdullaev et al, 2002). In addition, intranasal oxytocin was suggested to be associated with increased left TPJ activation during social cognitive tasks linked to prosocial actions (Hu et al, 2016).…”
Section: Discussionmentioning
confidence: 99%